KalVista Pharmaceuticals (KALV) Other Gross PP&E Adjustments (2016 - 2024)
Historic Other Gross PP&E Adjustments for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to -$9.5 million.
- KalVista Pharmaceuticals' Other Gross PP&E Adjustments changed N/A to -$9.5 million in Q4 2024 from the same period last year, while for Apr 2025 it was -$499000.0, marking a year-over-year increase of 8935.81%. This contributed to the annual value of -$4.7 million for FY2024, which is N/A changed from last year.
- KalVista Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$9.5 million in Q4 2024.
- KalVista Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $1.6 million during Q2 2020, with a 5-year trough of -$9.8 million in Q4 2024.
- Moreover, its 4-year median value for Other Gross PP&E Adjustments was -$6.5 million (2024), whereas its average is -$5.4 million.
- Over the last 5 years, KalVista Pharmaceuticals' Other Gross PP&E Adjustments had its largest YoY gain of 1497.27% in 2020, and its largest YoY loss of 188139.53% in 2020.
- Over the past 4 years, KalVista Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$1.7 million in 2020, then dropped by 11.02% to -$1.9 million in 2021, then tumbled by 373.95% to -$9.0 million in 2023, then decreased by 5.25% to -$9.5 million in 2024.
- Its Other Gross PP&E Adjustments stands at -$9.5 million for Q4 2024, versus -$9.8 million for Q4 2024 and -$9.4 million for Q3 2024.